Home/Filings/4/0001209191-18-004900
4//SEC Filing

Daly Timothy 4

Accession 0001209191-18-004900

CIK 0001636651other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:37 PM ET

Size

5.5 KB

Accession

0001209191-18-004900

Insider Transaction Report

Form 4
Period: 2018-01-19
Daly Timothy
VP, Finance & Corp. Controller
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-01-19+30,00030,000 total
    Exercise: $9.18Exp: 2028-01-18Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001535896

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:37 PM ET
Size
5.5 KB